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Abstract Prostaglandin F2K, platelet-derived growth factor
(PDGF) and calcium ionophore A23187 stimulated the rapid
(within 25 s) generation of polyunsaturated 1,2-diacylglycerol
(DAG) species, in particular 18:0/20:3n-9, 18:0/20:4n-6 and
18:0/20:5n-3, in Swiss 3T3 fibroblasts. This was followed by a
second sustained phase characterised by saturated, monounsatu-
rated and diunsaturated DAG species derived, at least partially,
from a phospholipase D/phosphatidate phosphohydrolase-linked
pathway. This could be directly activated by phorbol ester. Assay
of rat brain protein kinase C (PKC) in lipid vesicles showed that
first phase, polyunsaturated-enriched DAG isolated from Swiss
3T3 cells was a more potent activator of kinase activity
compared to that achieved with DAG from control or 5 min
stimulated cells. Thus activation of distinct members of the
phospholipase C family leads to the rapid and almost identical
generation of polyunsaturated DAG species which are capable of
preferentially activating protein kinase C (PKC).
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1. Introduction
The mechanism and role of lipid messenger generation dur-
ing signal transduction is still incompletely understood. How-
ever, one of the earliest events following stimulation is the
phospholipase C (PLC)-catalysed generation of inositol
1,4,5-trisphosphate (IP3) and the diradylglycerol (DRG) 1,2-
diacylglycerol (DAG), the physiological activator of protein
kinase C (PKC) [1^5]. The other DRGs, 1-alkyl,2-acylglycerol
and 1-alkenyl,2-acylglycerol, are poor PKC activators and in-
deed may act physiologically to downregulate this kinase [6].
At least three di¡erent PLCs appear able to generate the
rapid ¢rst phase in Swiss 3T3 cells : phosphatidylinositol 4,5-
bisphosphate (PtdInsP2)-PLCL which is coupled to receptors
through the heterotrimeric G-protein Gq/G11 (e.g. bombesin,
vasopressin [7,8,20]), PtdInsP2-PLCQ which is activated via
receptor tyrosine kinases (e.g. platelet-derived growth factor
(PDGF) [9,20]) and a PKC-independent, probably polyunsat-
urated PtdCho-speci¢c PLC (epidermal growth factor (EGF)
[10,11]). Despite reports of an interaction with the Gh GTP-
binding protein, it is unclear if PtdInsP2-PLCN can couple to a
receptor via a G-protein, however it may be activated by
changes in IP3 and Ca2 concentration [20].
PKC has a multiplicity of roles including the attenuation of
the initial PLC reaction (preventing sustained PtdInsP2 hy-
drolysis) and activation of a second phase of DAG produc-
tion via a sequential phospholipase D (PLD)/phosphatidate
phosphohydrolase (PAP) pathway and possibly another
PLC pathway [12^14]. The ¢rst phase of stimulated DAG
generation is normally maximal within 30 s, whilst the second
phase rises shortly thereafter, often remaining elevated for
30 min or more.
In 3T3 ¢broblasts PLD is activated by many agents (e.g.
bombesin [7,8], EGF [11], PDGF [9], PGF2K [7], vasopressin
[7], calcium ionophore, A23187 [8], tetradecanoyl phorbol ace-
tate (TPA) [8]) but only some produce a PAP-catalysed DAG
accumulation (e.g. TPA, bombesin [8,11]). Thus, acute DAG
production is not necessarily the consequence of PLD activa-
tion, suggesting that PtdOH has a signalling role in its own
right [14,15]. If so, PAP activity would be a mechanism to
attenuate the PtdOH signal and enable re-synthesis of the
parent phospholipid. The observation that only DAG derived
from phosphatidylcholine (PtdCho) via a PLD/PAP-linked
pathway was required to induce cytidyltransferase transloca-
tion and subsequent choline incorporation to reform PtdCho
in neutrophils [16], together with our recent work on porcine
aortic endothelial cells where we presented evidence that PLD/
PAP-generated DAG (saturated, monounsaturated and diun-
saturated species) is a poor activator of PKC in vivo [17],
supports this proposal. This implies that PKC activation in
vivo requires a di¡erent set of DAG species, probably the
polyunsaturated forms.
To address this issue we investigated the e¡ect of four dis-
similar agents upon DAG generation: the growth factor
PDGF which acts through a tyrosine kinase, the eicosanoid
PGF2K which acts through a G-protein-coupled receptor,
TPA which directly activates PKC and the calcium ionophore
A23187 which induces elevated intracellular [Ca2]. The re-
sults show that a common cellular response to a variety of
stimuli is the rapid and transient generation of an almost
identical set of polyunsaturated DAG species even though
the PLC enzyme involved may be di¡erent. This is followed
by the more sustained production of mostly saturated and
monounsaturated DAG species coming, at least partially,
via a PtdCho-PLD/PAP-linked pathway. In a lipid vesicle
assay, the polyunsaturated species are stronger activators of
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PKC than those species found in control cells or generated
during the second phase of acute DAG production.
2. Materials and methods
All solvents were of high-performance liquid chromatography
(HPLC) or analytical grade, purchased from Rathburn Chemicals
Ltd., Walkerburn, Scotland, UK. Human recombinant LL-PDGF
was from Gibco-BRL. Calcium ionophore A23187, PGF2K, TPA, his-
tone and all other chemicals were obtained from Sigma Chemical Co.
Ltd., Poole, Dorset, UK. Swiss 3T3 mouse ¢broblasts were cultured
in Dulbecco’s Modi¢ed Eagle’s Medium containing 10% newborn calf
serum until approximately 95% con£uent and then in medium con-
taining 2% serum for a further 24 h to quiesce the cells.
Fibroblasts were stimulated in triplicate as previously described
[10,18]. Optimum, maximally e¡ective concentrations were determined
in earlier work (PDGF, 30 ng/ml [9]; PGF2K, 1 WM [7]; A23187,
5 WM; TPA, 100 nM [8]). Where required, 30 mM butan-1-ol (to
block DRG generation via the PLD/PAP pathway) or 10 WM Ro-
31.8220 (to block the kinase activity of PKC) was added to the HBG
5 min prior to stimulation. Incubations were stopped by aspiration of
the medium followed by addition of 2 ml ice-cold methanol together
with internal standard (1 Wg 1,2-12:0/12:0 DAG). Lipids were ex-
tracted, derivatised with 3,5-dinitrobenzoylchloride, separated by
HPLC and identi¢ed as in earlier work [10,18]. DAG for the PKC
assay was quanti¢ed using the DAG kinase mass assay [21].
PKC assays were performed in glass tubes (50 Wl/sample) using a
mixed lipid vesicle system (sonicated until fully dispersed) containing
450 WM egg PtdCho, 50 WM bovine brain phosphatidylserine (PtdSer),
0.5 WM DAG (or 0.5 WM TPA for positive control), 200 Wg/ml histone
type IIIS (Sigma) in kinase bu¡er (50 mM HEPES, pH 7.5, 75 mM
KCl, 20 mM L-glycerophosphate, 10 mM MgCl2, 1 mM sodium or-
thovanadate, 0.1 mM CaCl2) and rat brain mixed PKCs (Calbio-
chem). Reactions were started by addition of 0.5 WCi [Q-32P]-ATP at
a ¢nal concentration of 20 WM. Following incubation for 2 h at 35‡C
the reaction was stopped with 50 Wl boiling 2U gel loading bu¡er
(0.125 M Tris-HCl, pH 6.8, 20% glycerol, 4% SDS, 0.01% bromo-
phenol), boiled for a further 5 min and separated on 17.5% SDS-
polyacrylamide gels. The phosphorylated histone band was detected
and quanti¢ed using a phosphorimager.
3. Results and discussion
Quiescent Swiss 3T3 mouse ¢broblasts contain approxi-
mately 4 nmol DRG/107 cells and have a basal DAG molec-
ular species pro¢le most closely resembling that of total cel-
lular PtdCho (see [18]). Stimulation with A23187, PDGF,
PGF2K or TPA caused time-dependent changes in total
DAG mass (Table 1). PDGF, PGF2K and A23187 all stimu-
lated an elevation at 25 s which returned to basal levels within
5 min for A23187 and PGF2K and within 30 min for PDGF.
Only with the phorbol ester was total DAG mass still signi¢-
cantly elevated at 30 min. This was probably due to PKC
activation causing sustained stimulation of downstream phos-
pholipases hence leading to a prolonged DAG signal. Using
the DAG kinase-linked assay we previously showed that
PDGF stimulated a biphasic elevation in total DRG mass
[9] whereas TPA only stimulated a monophasic response [8].
However, this methodology was unable to distinguish between
the DRG classes. HPLC separation of these classes demon-
strated no changes in 1-alkyl,2-acylglycerol or 1-alkenyl,2-
acylglycerol even though they represent approximately 30%
of the total basal DRG (30% alkyl,acylglycerol, 6 1% alke-
nyl,acylglycerol). This is similar to stimulation with bombesin
[18] and EGF [10], neither of which had any acute e¡ect on
these classes even though the most likely substrates for sec-
ond-phase DRG generation, PtdCho and PtdEtn, contain sig-
ni¢cant amounts of alkyl,acyl and alkenyl,acyl forms [18].
Thus diacyl phospholipids are selectively hydrolysed to gen-
erate DAG in response to receptor stimulation. This may be
due to compartmentalisation where the relevant phospholip-
ase only has access to diacyl species or, alternatively, the
enzyme(s) may be speci¢c for lipids containing an ester
bond (with two oxygen atoms) at the sn-1 position. This is
not speci¢c to Swiss 3T3 cells since a similar response was
obtained in TPA-stimulated Madin-Darby canine kidney cells
where diacyl- but not alkyl,acyl glycerol species were elevated
[19].
PDGF, PGF2K and A23187 stimulated the greatest changes
in DAG pro¢les (relative to the basal pro¢le) at the 25-s time
point. Most of the increased mass was due to an elevation of
polyunsaturated species, in particular 18:1n-9/20:3n-9, 18:0/
20:3n-9, 18:0/20:4n-6 and 18:0/20:5n-3 (Fig. 1). PGF2K stim-
ulates a receptor/G-protein/PtdInsP2-PLCL coupled mecha-
nism in these cells [7] whilst PDGF activates PtdInsP2-PLCQ
via a receptor tyrosine kinase. Since elevated cytosolic [Ca2]
can activate phosphoinositide-PLC [2,20], in particular PLCN,
the A23187 may initially activate this enzyme. Therefore the
results in Fig. 1 could suggest that PLCN, like PLCL and
PLCQ , generates primarily polyunsaturated DAGs. Agonists
which, through the generation of IP3 by either PLCL or
PLCQ , stimulate an elevation of cytosolic [Ca2] could also
activate PLCN, giving a combined e¡ect which might enhance
the polyunsaturated DAG changes. The small, rapid and tran-
sient elevation of total DAG often seen in control samples,
probably resulting from the small, unavoidable environmental
£uctuations induced during the experimental protocol (e.g.
temperature, sheer forces, mixing e¡ects), may be caused by
transient cytosolic Ca2 changes activating this PLCN.
The rapid initial phase of DAG generation is followed by a
second, more sustained phase. Close examination of the mo-
lecular species pro¢les indicated that for PDGF, PGF2K and
A23187 another source is utilised to produce this second
phase of DAG elevation. This pro¢le is characterised predom-




Changes in total 1,2-diacylglycerol mass following stimulation of 3T3 ¢broblasts with PDGF, PGF2K, calcium ionophore (A23187) or phorbol
ester (TPA)
% of basal DAG þ S.D.
PDGF PGF2K A23187 TPA
Control 100 þ 7 100 þ 6 100 þ 6 100 þ 12
25 s 182 þ 32* 167 þ 26* 125 þ 19* ND
5 min 142 þ 26* 100 þ 20 98 þ 14 140 þ 7*
30 min 117 þ 23 104 þ 24 112 þ 25 148 þ 24*
n 4 3 3 3
Basal DAG = 3 nmol/107 cells. ND = not determined. *Signi¢cantly elevated above controls (P6 0.05).
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Fig. 1.
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Fig. 1 (Continued).
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18:1n-9/18:1n-9, 16:0/18:1n-9+18:0/18:2n-6, 16:0/18:0; Fig.
1) although the kinetics of their generation varied depending
on the stimulus. Since this source produced DAG species with
a pro¢le very similar to that of the basal DAG (although the
mass of individual species is elevated, Fig. 1A, the relative
proportions of each species resembles that of the control,
Fig. 1B) which in turn most closely resembles the acyl pro¢le
of total PtdCho (see [18]), the data suggests this phospholipid
as the probable substrate for phospholipase-catalysed gener-
ation of the second-phase diacyl species.
PDGF-stimulated second phase DAG generation was de-
tectable at 25 s, where it underlay the elevation of the poly-
unsaturated species, was maximal at 5 min and still elevated at
30 min. We previously showed that the PDGF-elevated sec-
ond-phase DAG is probably derived via a PKC-dependent,
PtdCho-speci¢c PLD/PAP-linked pathway [9]. We also
showed that phosphoinositide hydrolysis was slower than
that seen with bombesin, commencing after a lag phase of
approximately 15 s, and was detectable for up to 5 min.
The slightly raised levels of 18:1n-9/20:3n-9 and 18:0/20:3n-
9 detected at 5 min (although less than at 25 s), but not at 30
min would con¢rm this. In contrast, bombesin-stimulated
PtdInsP2-PLC activity is rapidly desensitised and a putative
PtdCho-PLC might be responsible for many of the late DAG
changes. With bombesin, PAP-catalysed hydrolysis of PtdOH
only starts making a signi¢cant contribution after 5 min,
although by 30 min all DAG is generated by this pathway
[8,11,17,18].
The PGF2K-stimulated second phase of DAG generation
(characterised by more saturated species) was maximal at 25
s (where it overlay the polyunsaturated DAG of the initial
phase) declining at 5 min and was undetectable by 30 min
(Fig. 1A). Since the ¢rst and second phases partially overlap
and the shortest time point examined was 25 s, both phases
appear to be maximal at this time. Whilst the identity of the
phospholipase(s) responsible for this second phase remains
uncertain, a PLD/PAP-linked pathway is implicated since
PGF2K stimulated the formation of phosphatidylalcohol in
the presence of butanol [7].
A PLD/PAP-linked pathway is probably also activated by
the calcium ionophore since A23187 has been shown to stim-
ulate PLD activity in Swiss 3T3 cells [8]. Treatment with
EGTA or a PKC inhibitor reduced A23187-induced PLD ac-
tivity by approximately 50%, however, the e¡ects were not
additive [8], suggesting that both extracellular Ca2 in£ux
and the inhibitor operate through the same signalling compo-
nent, possibly the more calcium-dependent PKCK.
To examine the role of PKC activation in DAG generation,
phorbol ester was used to stimulate the kinase directly. Since
our earlier work found little change in DAG levels before
1 min [8] only the 5- and 30-min time points were investigated.
TPA caused no signi¢cant changes from the basal DAG spe-
cies pro¢le at 5 min although total mass was elevated (Table
1). However, a small increase in the proportion of 18:1n-9/
18:1n-9 and 18:0/18:1n-9 species was evident at 30 min (Fig.
1). Based on the species pro¢le, the detection of elevated levels
of choline metabolites [7] and the inability to detect any re-
lease of inositol or inositol phosphates, this DAG must arise
from PtdCho hydrolysis and probably corresponds to the sec-
ond phase of DAG generation seen with the other stimuli.
The PKC inhibitor Ro-31.8220 completely abolished the
DAG mass increases (Table 2), but had no e¡ect on the spe-
cies pro¢les (data not shown). Thus TPA directly stimulates
PKC causing the activation of the second phase without the
preceding polyunsaturated DAG phase. The DAG changes
could be completely blocked by butanol, indicating the
PLD/PAP-linked pathway as the primary route of DAG gen-
eration (Table 2). Analysis of PtdOH from 3T3 ¢broblasts
challenged with a variety of stimuli, including TPA, detected
the production of predominantly saturated, monounsaturated
and diunsaturated species, with almost no polyunsaturated
structures at any time [17]. This supports our proposals that
only the more saturated DAG species are produced via the
PLD/PAP-linked pathway.
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Fig. 2. Activation of rat brain PKC by 500 nM TPA or 500 nM
DAG isolated from resting (control), 20-s and 5-min bombesin-
stimulated Swiss 3T3 ¢broblasts. Lipid vesicles contained 450 WM
PtdCho, 50 WM PtdSer, 200 Wg/ml histone type IIIS and 20 WM
[32P]-ATP. Phosphorylated histone was separated on 17.5% SDS-
polyacrylamide gels and quanti¢ed using a phosphorimager. Values
are fold increase in histone phosphorylation þ S.D. (n = 3).
Table 2
Inhibition of TPA-stimulated DAG mass changes by butanol and
Ro-31.8220
% of basal DAG þ S.D.
TPA TPA+butanol TPA+Ro31.8220
Control 100 þ 12 89 þ 16 99 þ 27
5 min 144 þ 9 82 þ 31* 105 þ 10*
30 min 155 þ 10 64 þ 8* 73 þ 10*
n 6 3 3
Basal DAG = 3 nmol/107 cells. *Signi¢cantly reduced relative to TPA
alone (P6 0.05).
Fig. 1. Changes in DAG species pro¢les following stimulation with calcium ionophore (A23187), PDGF, PGF2K or phorbol ester (TPA). Data
expressed as (A) absolute mass of each species (pmol/107 cells) þ S.D. (n = 3^4) or (B) as a percentage of total cellular DAG mass þ S.D. (n =
3^4). Over 30 DAG species were identi¢ed; however, the minor species (each representing 6 0.5% of total DAG) have been omitted from the
¢gure. b, species signi¢cantly elevated at 25 s; P6 0.05 using Student’s paired t-test.
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To investigate PKC activation by the di¡erent DAG
phases, DAG was isolated from resting (control) Swiss 3T3
¢broblasts and from cells treated for 20 s or 5 min with bomb-
esin (a strong stimulator of biphasic DAG generation [18]).
This DAG was then used at a ¢nal concentration of 0.5 WM
(0.1 mol%) in a lipid vesicle assay containing PtdCho (90
mol%) and PtdSer (10 mol%), histone and rat brain PKC (a
mixture of PKC isoenzymes including K, L, Q, N, O and j). A
typical result is shown in Fig. 2 where DAG isolated from
cells stimulated for 20 s (and thus enriched in polyunsaturated
species [18]) showed an increase in PKC activity as compared
to samples containing the DAG from control or 5 min stimu-
lated cells. Experiments using de¢ned, single DAG species
con¢rmed that 18:0/20:4n-6 (the major species generated dur-
ing the initial, rapid phase) induced a slightly greater PKC
activation than 18:1n-9/18:1n-9 (a major species generated
during the second phase via the PLD/PAP pathway [17]), a
result seen by another group using a slightly di¡erent vesicle
system [22]. Support for this concept of the importance of the
initial polyunsaturated DAG phase comes from work with
pancreatic acini where PtdInsP2-derived DAG (enriched in
polyunsaturated species) caused PKC translocation, whereas
DAG derived from PtdCho did not [23] and with platelets
where thrombin stimulation caused elevation in several
DAG species but only elevation of 18:0/20:4n-6 correlated
with PKC activation as measured by pleckstrin phosphoryla-
tion [24].
In conclusion, acute stimulation of Swiss 3T3 cells induces
the rapid generation of polyunsaturated DAG species derived
via PtdInsP2-PLCL (bombesin, PGF2K), PtdInsP2-PLCQ
(PDGF) or PtdInsP2-PLCN (A23187) pathways depending
on the stimulatory agent involved. Since the resultant DAG
species are e¡ectively identical, the PtdInsP2-PLC isoenzymes
must utilise a common source of PtdInsP2. This suggests that
these DAG species are essential for the activation of an im-
mediate and common downstream target, presumably a spe-
ci¢c PKC isoform(s) which often inactivates the initial phase
and also stimulates a second phase of DAG generation de-
rived, at least in part, via a PLD/PAP-linked pathway. This
DAG, characterised by a more saturated pro¢le, is probably
largely inactive as an intracellular messenger. It remains to be
con¢rmed that the PLC-generated polyunsaturated ‘early’
DAG species are indeed the speci¢c physiological activators
of PKC in vivo, a function which cannot be e¡ectively
achieved by other, more saturated species. However, the re-
sults reported here strongly suggest a structural speci¢city for
the messenger DAG in its capacity as an activator of PKC.
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